Orange County is about to see the first initial public offering of 2025. Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to ...
Based on the one-year price targets offered by 11 analysts, the average target price for Beta Bionics Inc (NASDAQ:BBNX) is $28.82, with a high estimate of $40.00 and a low estimate of $17.00. The ...
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, unaudited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results